Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 250MG | 0 | CHLOROQUINE PHOSPHATE | CHLOROQUINE PHOSPHATE |
FDA Submissions
| ORIG | 1 | AP | 1974-12-11 | |
LABELING; Labeling | SUPPL | 39 | AP | 1988-11-22 | |
LABELING; Labeling | SUPPL | 40 | AP | 1988-12-15 | |
LABELING; Labeling | SUPPL | 43 | AP | 1996-10-11 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 45 | AP | 1997-07-18 | |
LABELING; Labeling | SUPPL | 63 | AP | 2020-04-30 | STANDARD |
LABELING; Labeling | SUPPL | 65 | AP | 2022-03-17 | STANDARD |
LABELING; Labeling | SUPPL | 66 | AP | 2022-05-03 | STANDARD |
Submissions Property Types
SUPPL | 45 | Null | 0 |
SUPPL | 63 | Null | 15 |
SUPPL | 65 | Null | 15 |
SUPPL | 66 | Null | 15 |
TE Codes
CDER Filings
IMPAX LABS
cder:Array
(
[0] => Array
(
[ApplNo] => 80880
[companyName] => IMPAX LABS
[docInserts] => ["",""]
[products] => [{"drugName":"CHLOROQUINE PHOSPHATE","activeIngredients":"CHLOROQUINE PHOSPHATE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"CHLOROQUINE PHOSPHATE","submission":"CHLOROQUINE PHOSPHATE","actionType":"250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)